Clinical Trial Update: Early Prediction of Fluoxetine Response [Phase 4]

View source ↗

Summary

Phase 4 trial assessing early predictors of fluoxetine response in adults with Major Depressive Disorder has completed. The sponsor is Kaohsiung Kai-Suan Psychi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: Kaohsiung Kai-Suan Psychiatric Hospital | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED